161 related articles for article (PubMed ID: 21820032)
21. Novel interactions of the mineralocorticoid receptor.
Fuller PJ
Mol Cell Endocrinol; 2015 Jun; 408():33-7. PubMed ID: 25662276
[TBL] [Abstract][Full Text] [Related]
22. Identification and characterization of a ligand-selective mineralocorticoid receptor coactivator.
Rogerson FM; Yao YZ; Young MJ; Fuller PJ
FASEB J; 2014 Oct; 28(10):4200-10. PubMed ID: 24907116
[TBL] [Abstract][Full Text] [Related]
23. Comparative inhibition by hard and soft metal ions of steroid-binding capacity of renal mineralocorticoid receptor cross-linked to the 90-kDa heat-shock protein heterocomplex.
Galigniana MD; Piwien-Pilipuk G
Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):585-92. PubMed ID: 10417321
[TBL] [Abstract][Full Text] [Related]
24. Ligand-induced conformational change in the human mineralocorticoid receptor occurs within its hetero-oligomeric structure.
Couette B; Fagart J; Jalaguier S; Lombes M; Souque A; Rafestin-Oblin ME
Biochem J; 1996 Apr; 315 ( Pt 2)(Pt 2):421-7. PubMed ID: 8615809
[TBL] [Abstract][Full Text] [Related]
25. Interactions of the mineralocorticoid receptor--within and without.
Yang J; Fuller PJ
Mol Cell Endocrinol; 2012 Mar; 350(2):196-205. PubMed ID: 21784126
[TBL] [Abstract][Full Text] [Related]
26. Structural determinants of aldosterone binding selectivity in the mineralocorticoid receptor.
Rogerson FM; Dimopoulos N; Sluka P; Chu S; Curtis AJ; Fuller PJ
J Biol Chem; 1999 Dec; 274(51):36305-11. PubMed ID: 10593921
[TBL] [Abstract][Full Text] [Related]
27. A ligand-mediated hydrogen bond network required for the activation of the mineralocorticoid receptor.
Bledsoe RK; Madauss KP; Holt JA; Apolito CJ; Lambert MH; Pearce KH; Stanley TB; Stewart EL; Trump RP; Willson TM; Williams SP
J Biol Chem; 2005 Sep; 280(35):31283-93. PubMed ID: 15967794
[TBL] [Abstract][Full Text] [Related]
28. Nuclear shuttling precedes dimerization in mineralocorticoid receptor signaling.
Grossmann C; Ruhs S; Langenbruch L; Mildenberger S; Strätz N; Schumann K; Gekle M
Chem Biol; 2012 Jun; 19(6):742-51. PubMed ID: 22726688
[TBL] [Abstract][Full Text] [Related]
29. Molecular determinants of the recognition of ulipristal acetate by oxo-steroid receptors.
Petit-Topin I; Fay M; Resche-Rigon M; Ulmann A; Gainer E; Rafestin-Oblin ME; Fagart J
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt B():427-35. PubMed ID: 25204619
[TBL] [Abstract][Full Text] [Related]
30. Mechanistic aspects of mineralocorticoid receptor activation.
Hellal-Levy C; Fagart J; Souque A; Rafestin-Oblin ME
Kidney Int; 2000 Apr; 57(4):1250-5. PubMed ID: 10760050
[TBL] [Abstract][Full Text] [Related]
31. Molecular mechanism of activation and nuclear translocation of the mineralocorticoid receptor upon binding of pregnanesteroids.
Galigniana MD; Piwien Pilipuk G; Kanelakis KC; Burton G; Lantos CP
Mol Cell Endocrinol; 2004 Mar; 217(1-2):167-79. PubMed ID: 15134815
[TBL] [Abstract][Full Text] [Related]
32. Evidence for NL1-independent nuclear translocation of the mineralocorticoid receptor.
Piwien Pilipuk G; Vinson GP; Sanchez CG; Galigniana MD
Biochemistry; 2007 Feb; 46(5):1389-97. PubMed ID: 17260968
[TBL] [Abstract][Full Text] [Related]
33. Modification of an essential amino group in the mineralocorticoid receptor evidences a differential conformational change of the receptor protein upon binding of antagonists, natural agonists and the synthetic agonist 11,19-oxidoprogesterone.
Piwien-Pilipuk G; Kanelakis KC; Ghini AA; Lantos CP; Litwack G; Burton G; Galigniana MD
Biochim Biophys Acta; 2002 Feb; 1589(1):31-48. PubMed ID: 11909639
[TBL] [Abstract][Full Text] [Related]
34. The synthetic androgen methyltrienolone (r1881) acts as a potent antagonist of the mineralocorticoid receptor.
Takeda AN; Pinon GM; Bens M; Fagart J; Rafestin-Oblin ME; Vandewalle A
Mol Pharmacol; 2007 Feb; 71(2):473-82. PubMed ID: 17105867
[TBL] [Abstract][Full Text] [Related]
35. Rapid mineralocorticoid receptor trafficking.
Gekle M; Bretschneider M; Meinel S; Ruhs S; Grossmann C
Steroids; 2014 Mar; 81():103-8. PubMed ID: 24252381
[TBL] [Abstract][Full Text] [Related]
36. Determinants of spironolactone binding specificity in the mineralocorticoid receptor.
Rogerson FM; Yao YZ; Smith BJ; Dimopoulos N; Fuller PJ
J Mol Endocrinol; 2003 Dec; 31(3):573-82. PubMed ID: 14664717
[TBL] [Abstract][Full Text] [Related]
37. Aldosterone, mineralocorticoid receptor, and heart failure.
Messaoudi S; Azibani F; Delcayre C; Jaisser F
Mol Cell Endocrinol; 2012 Mar; 350(2):266-72. PubMed ID: 21784127
[TBL] [Abstract][Full Text] [Related]
38. New naturally occurring missense mutations of the human mineralocorticoid receptor disclose important residues involved in dynamic interactions with deoxyribonucleic acid, intracellular trafficking, and ligand binding.
Sartorato P; Cluzeaud F; Fagart J; Viengchareun S; Lombès M; Zennaro MC
Mol Endocrinol; 2004 Sep; 18(9):2151-65. PubMed ID: 15192075
[TBL] [Abstract][Full Text] [Related]
39. Histone Deacetylase 6-Controlled Hsp90 Acetylation Significantly Alters Mineralocorticoid Receptor Subcellular Dynamics But Not its Transcriptional Activity.
Jiménez-Canino R; Lorenzo-Díaz F; Jaisser F; Farman N; Giraldez T; Alvarez de la Rosa D
Endocrinology; 2016 Jun; 157(6):2515-32. PubMed ID: 27100623
[TBL] [Abstract][Full Text] [Related]
40. Crystal structure of the mineralocorticoid receptor ligand-binding domain in complex with a potent and selective nonsteroidal blocker, esaxerenone (CS-3150).
Takahashi M; Ubukata O; Homma T; Asoh Y; Honzumi M; Hayashi N; Saito K; Tsuruoka H; Aoki K; Hanzawa H
FEBS Lett; 2020 May; 594(10):1615-1623. PubMed ID: 31991486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
